Tag: Tmax (time to maximum concentration)

BA-BE Studies: SOP for Developing Study Synopsis for Ethics Submission – V 2.0

Posted on By

BA-BE Studies: SOP for Developing Study Synopsis for Ethics Submission – V 2.0 Standard Operating Procedure for Developing Study Synopsis for Ethics Submission in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/007/2025 Supersedes SOP/BA-BE/007/2022 Page No. Page 1 of 12 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define the standard…

Read More “BA-BE Studies: SOP for Developing Study Synopsis for Ethics Submission – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Fasted vs Fed Study Design Selection – V 2.0

Posted on By

BA-BE Studies: SOP for Fasted vs Fed Study Design Selection – V 2.0 Standard Operating Procedure for Fasted vs Fed Study Design Selection in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/006/2025 Supersedes SOP/BA-BE/006/2022 Page No. Page 1 of 12 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define the criteria…

Read More “BA-BE Studies: SOP for Fasted vs Fed Study Design Selection – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Dose Selection Criteria for BA/BE Studies – V 2.0

Posted on By

BA-BE Studies: SOP for Dose Selection Criteria for BA/BE Studies – V 2.0 Standard Operating Procedure for Dose Selection Criteria in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/005/2025 Supersedes SOP/BA-BE/005/2022 Page No. Page 1 of 12 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To establish a standardized process for selecting…

Read More “BA-BE Studies: SOP for Dose Selection Criteria for BA/BE Studies – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Selecting Bioequivalence Study Design (Crossover, Parallel, etc.) – V 2.0

Posted on By

BA-BE Studies: SOP for Selecting Bioequivalence Study Design (Crossover, Parallel, etc.) – V 2.0 Standard Operating Procedure for Selecting Bioequivalence Study Design in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/004/2025 Supersedes SOP/BA-BE/004/2022 Page No. Page 1 of 13 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To outline the procedure for…

Read More “BA-BE Studies: SOP for Selecting Bioequivalence Study Design (Crossover, Parallel, etc.) – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Designing Clinical Study Protocol for BA/BE – V 2.0

Posted on By

BA-BE Studies: SOP for Designing Clinical Study Protocol for BA/BE – V 2.0 Standard Operating Procedure for Designing Clinical Study Protocol for BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/003/2025 Supersedes SOP/BA-BE/003/2022 Page No. Page 1 of 14 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define a structured approach for…

Read More “BA-BE Studies: SOP for Designing Clinical Study Protocol for BA/BE – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Reviewing Reference Product Literature – V 2.0

Posted on By

BA-BE Studies: SOP for Reviewing Reference Product Literature – V 2.0 Standard Operating Procedure for Reviewing Reference Product Literature in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/002/2025 Supersedes SOP/BA-BE/002/2022 Page No. Page 1 of 12 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define the procedure for identifying, retrieving, and…

Read More “BA-BE Studies: SOP for Reviewing Reference Product Literature – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Planning of BA/BE Studies – V 2.0

Posted on By

BA-BE Studies: SOP for Planning of BA/BE Studies – V 2.0 Standard Operating Procedure for Planning of BA/BE Studies in Pharmaceutical Development Department BA-BE Studies SOP No. SOP/BA-BE/001/2025 Supersedes SOP/BA-BE/001/2022 Page No. Page 1 of 13 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To establish a systematic and standardized approach for…

Read More “BA-BE Studies: SOP for Planning of BA/BE Studies – V 2.0” »

BA-BE Studies V 2.0

SOP for Post-study Follow-up

Posted on By

Protocol for Participant Monitoring after BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for conducting post-study follow-up activities with participants who have completed Bioavailability (BA) and Bioequivalence (BE) studies, ensuring their ongoing well-being, providing necessary support, and facilitating long-term data collection. Scope This SOP applies to all study…

Read More “SOP for Post-study Follow-up” »

Bioequivalence Bioavailability Study

SOP for Study Termination Procedures

Posted on By

Protocol for Ending BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the termination of Bioavailability (BA) and Bioequivalence (BE) studies, ensuring proper closure of study activities, data collection, and documentation in accordance with regulatory requirements and study protocols. Scope This SOP applies to all study personnel involved…

Read More “SOP for Study Termination Procedures” »

Bioequivalence Bioavailability Study

SOP for Handling Unblinding Procedures

Posted on By

Protocol for Unmasking Treatment Allocation in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the handling of unblinding procedures in Bioavailability (BA) and Bioequivalence (BE) studies, ensuring appropriate disclosure of treatment allocation while maintaining study integrity and participant confidentiality. Scope This SOP applies to all study personnel…

Read More “SOP for Handling Unblinding Procedures” »

Bioequivalence Bioavailability Study